Literature DB >> 2679152

Role of hemodynamic factors in osmoregulatory alterations of rat pregnancy.

W M Barron1, J A Dürr, R W Schrier, M D Lindheimer.   

Abstract

Plasma osmolality (Posmol) decreases in pregnancy, possibly because of hemodynamically mediated arginine vasopressin (AVP) secretion, i.e., inadequate vascular filling and/or decreased blood pressure. This hypothesis was tested in Sprague-Dawley rats treated on gestational days 1-18 or 13-18 with 1) deoxycorticosterone acetate (DOCA) + standard chow (0.5% Na), 2) vehicle + standard chow, or 3) high-Na (1.25%) diet. Renal sodium "escape" and suppression of the renin-aldosterone system suggested "effective volume expansion," yet Posmol was similar in all pregnant groups, 7-10 mosmol/kg below levels in virgin controls, and plasma AVP was unaltered. Apparent osmotic thresholds for AVP secretion, similar in control and DOCA-treated gravid animals, were 8-10 mosmol/kg below those of untreated virgin rats. Norepinephrine + DOCA, administered to gravid animals consuming normal or high-Na chow, increased blood pressure approximately 10% above control levels, but this also failed to alter Posmol. These data suggest that mechanisms other than hemodynamically mediated AVP secretion are responsible for the osmoregulatory alterations accompanying rodent pregnancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679152     DOI: 10.1152/ajpregu.1989.257.4.R909

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Computational simulation of vasopressin secretion using a rat model of the water and electrolyte homeostasis.

Authors:  Louis Nadeau; Danielle Arbour; Didier Mouginot
Journal:  BMC Physiol       Date:  2010-08-25

2.  Hyperbranched polyglycerol is an efficacious and biocompatible novel osmotic agent in a rodent model of peritoneal dialysis.

Authors:  Asher A Mendelson; Qiunong Guan; Irina Chafeeva; Gerald A da Roza; Jayachandran N Kizhakkedathu; Caigan Du
Journal:  Perit Dial Int       Date:  2013 Jan-Feb       Impact factor: 1.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.